New pouch aims to make mealtimes safer for Huntington's patients

NCT ID NCT07299682

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study was designed to test whether a reusable pouch called DoddleBags could help people with Huntington's disease eat more easily and safely. The pouch holds pureed food and can be used with an anti-choking cap or spoon attachment. The trial was withdrawn before any participants were enrolled, so no results are available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
DoddleBags (reusable flexible pouches for pureed food)
What this could lead to
If successful, DoddleBags could offer a simple, practical tool to help people with Huntington's disease feed themselves more easily and reduce choking risks.
What could go wrong
The study was withdrawn before enrolling any participants, so no data was collected. The device may not work for everyone or may not improve eating behaviors as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUNTINGTON'S DISEASE (HD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cambridge University Hospitals

    Cambridge, United Kingdom

  • Cardiff University

    Cardiff, United Kingdom

  • Leeds Teaching Hospitals

    Leeds, United Kingdom

  • Leicestershire Partnership NHS Trust

    Leicester, United Kingdom

  • NHS Greater Glasgow & Clyde

    Glasgow, United Kingdom

  • Sheffield Children's Hospital

    Sheffield, United Kingdom

  • Walton Centre NHST

    Liverpool, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.